Invisible virus is being evaluated as the next generation of compassionate cancer cures
August 10, 2012
The investigative FOXNews journalists caught up with the clinicians, nurses and researchers at California Veterinary Specialists Angel Care Cancer Center to learn how an invisible virus is being evaluated as the next generation of compassionate cancer cures in dogs, cats and people. Angel Care Cancer Center, a separate but allied non-profit research organization, the Special Care Foundation for Companion Animals and the San Diego based company Genelux have teamed up to affirm the safety an efficacy of a new cancer killing virus. The therapy includes a modification of a virus that has been used worldwide to wipe out smallpox as a threat to human health. Families who bring their beloved pets with cancer to Angel Care seek the highest level of advanced yet gentle cancer care and novel, new therapies that are likely to become the therapies of the future. The purpose of the study is to determine the optimum way of treating these dogs with cancer while taking these results to develop new approaches to enhance the cure rates in children and adults.
The CVS Angel Care Cancer Center is a comprehensive cancer center that provides direct care for patients with cancer and their families. This team offers innovative clinical research to provide the very best diagnostics and treatments available to fight against cancer. They are a group of veterinarians, veterinary nurses, and human physicians that share a mutual philosophy: science may provide a cure, but compassionate care comes from the heart. The goal is to do everything possible to not only win the fight against cancer, but to ensure the treatment is healing, not hurting.
Investigators from California Veterinary Specialists empowered by funding from the Special Care Foundation for Companion Animals, has worked with the discovery team led by Dr. Genevieve Hansen to develop a novel therapy for T-cell lymphoma in dogs. The veterinary oncologists and nurses at all three CVS hospitals (Murrieta, Ontario and Carlsbad) executed a series of clinical and basic science trials to document the safety and efficacy of the monoclonal antibody therapy that triggers the immune system to kill the T cell lymphoma cancer cells ...
Dr. Gregory Ogilvie, director of the CVS Angel Care Cancer Center, actively participated in and raised money for Pedal the Cause bike ride, a non-profit dedicated to raising money for cancer research at San Diego's three NCI-designated Cancer Institutes; UCSD Moores Cancer Center, The Salk Institute and Sanford-Burnham Medical Research Institute. The two-day ride covered 150 miles from La Jolla to Temecula. Pedal the Cause granted $425,000 from the 2013 ride and is expected to double that amount thanks to the brave donors who helped make t...
In case you missed it, check out last week’s KUSI-TV live segment with Dr. Ogilvie as he discusses cancer treatment for animals.
There are currently very promising developments in the treatment of canine cancer that focus on the natural immune response of the body. Cancer cells secrete elements into the blood that inhibit the immune system from killing them. The LW-2 Canine Therapy focuses on removing these harmful elements without the use of drugs, chemicals, radiation, or complicated surgical procedures. This approach is also intended to limit the possibilities and side effects traditionally associated with cancer treatments.
Recently, the Morris Animal Foundation had their annual San Diego K9 Cancer Walk and this year California Veterinary Specialists was out in full force. CVS had a booth and offered raffle prizes, a doggie cake and lots of smiles for anyone who stopped by. A big thank you goes to Leah Larscheidt, our team captain and an employee at our Carlsbad location, for organizing team Angel Care for the Cure. Leah and her faithful companion, Elvis, managed to help raise nearly $2,000 for the Morris Animal Foundation. Her team was awarded 2nd place in bot...